Literature DB >> 10873554

Activation of NADPH oxidase in Alzheimer's disease brains.

S Shimohama1, H Tanino, N Kawakami, N Okamura, H Kodama, T Yamaguchi, T Hayakawa, A Nunomura, S Chiba, G Perry, M A Smith, S Fujimoto.   

Abstract

The present study is the first to show that superoxide (O(-)(2)) forming NADPH oxidase is activated in Alzheimer's disease (AD) brains by demonstrating the marked translocation of the cytosolic factors p47-phox and p67-phox to the membrane. In conjunction with a recent in vitro study showing that amyloid beta activates O(-)(2) forming NADPH oxidase in microglia, where these phox proteins are localized in this study, the present results suggest that, in AD, NADPH oxidase is activated in microglia, resulting in the formation of reactive oxygen species which can be toxic to neighboring neurons in AD. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873554     DOI: 10.1006/bbrc.2000.2897

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  105 in total

Review 1.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

2.  NOX activity in brain aging: exacerbation by high fat diet.

Authors:  Annadora J Bruce-Keller; Christy L White; Sunita Gupta; Alecia G Knight; Paul J Pistell; Donald K Ingram; Christopher D Morrison; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2010-03-25       Impact factor: 7.376

Review 3.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

Review 4.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

5.  Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.

Authors:  Annadora J Bruce-Keller; Sunita Gupta; Alecia G Knight; Tina L Beckett; Jessica M McMullen; Paulina R Davis; M Paul Murphy; Linda J Van Eldik; Daret St Clair; Jeffrey N Keller
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

Review 6.  Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Tamar Amit
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

Review 7.  Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.

Authors:  Hans Lassmann
Journal:  J Neural Transm (Vienna)       Date:  2011-03-05       Impact factor: 3.575

8.  Diazoxide pretreatment prevents Aβ1-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression.

Authors:  Qingxi Fu; Naiyong Gao; Jixu Yu; Guozhao Ma; Yifeng Du; Fumin Wang; Quanping Su; Fengyuan Che
Journal:  Neurochem Res       Date:  2014-04-27       Impact factor: 3.996

Review 9.  Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia.

Authors:  Costantino Iadecola
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

10.  NADPH oxidase mediates beta-amyloid peptide-induced activation of ERK in hippocampal organotypic cultures.

Authors:  Faridis Serrano; Angela Chang; Caterina Hernandez; Robia G Pautler; J David Sweatt; Eric Klann
Journal:  Mol Brain       Date:  2009-10-05       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.